Table 2 Association between number of anti-hypertensive medication and injurious falls (N = 210)

 0

1.00

1.00

 1

0.92 (0.30–2.87)

2.10 (0.48–9.18)

  ≥ 2

4.75 (1.77–12.72)

5.45 (1.49–19.93)

Charlson comorbidity index

1.33 (1.14–1.56)

1.26 (1.04–1.54)

High risk of fall^a

5.69 (2.42–13.36)

7.21 (2.37–21.94)

Visual impairment

2.48 (1.01–6.08)

2.02 (0.70–5.86)

Exposure to psychotropic medication

2.21 (0.97–5.06)

1.12 (0.38–3.37)

Polypharmacy

2.22 (1.08–4.54)

1.29 (0.49–3.43)

Age (years)

0.92 (0.82–1.04)

BMI (kg/m²)

1.06 (0.98–1.13)

Chinese^c

2.99 (0.62–14.34)

SBP on admission (mmHg)

1.01 (0.99–1.03)

DBP on admission (mmHg)

1.01 (0.98–1.04)

Hearing impairment

1.27 (0.41–3.92)

Use of walking aid^b

8.18 (3.29–20.31)

Smoking history

1.06 (0.42–2.67)

Alcohol history

1.13 (0.34–3.74)

 Hypertension

1.05 (0.47–2.38)

 Cerebrovascular accident or transient ischaemic attack

1.97 (0.87–4.49)

 Ischaemic heart disease

1.26 (0.57–2.76)

 Diabetes mellitus

1.17 (0.60–2.28)

 Hyperlipidaemia

0.91 (0.44–1.89)

 Osteoporosis

1.05 (0.33–3.32)

 Cancer

1.28 (0.48–3.46)

 Cognitive impairment

1.33 (0.47–3.80)

Prior history of falls^b

2.51 (1.18–5.37)

Statin use

0.88 (0.45–1.71)